← Evidence map

ArticleScientific reports2020

Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer.

Katharina Leitner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33230143